These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 28373842)

  • 1. Breast Cancer Stem-Like Cells Are Inhibited by Diosgenin, a Steroidal Saponin, by the Attenuation of the Wnt β-Catenin Signaling via the Wnt Antagonist Secreted Frizzled Related Protein-4.
    Bhuvanalakshmi G; Basappa ; Rangappa KS; Dharmarajan A; Sethi G; Kumar AP; Warrier S
    Front Pharmacol; 2017; 8():124. PubMed ID: 28373842
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer stem-like cells from head and neck cancers are chemosensitized by the Wnt antagonist, sFRP4, by inducing apoptosis, decreasing stemness, drug resistance and epithelial to mesenchymal transition.
    Warrier S; Bhuvanalakshmi G; Arfuso F; Rajan G; Millward M; Dharmarajan A
    Cancer Gene Ther; 2014 Sep; 21(9):381-8. PubMed ID: 25104726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of breast cancer stem-like cells by a triterpenoid, ursolic acid, via activation of Wnt antagonist, sFRP4 and suppression of miRNA-499a-5p.
    Mandal S; Gamit N; Varier L; Dharmarajan A; Warrier S
    Life Sci; 2021 Jan; 265():118854. PubMed ID: 33278391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short peptide domains of the Wnt inhibitor sFRP4 target ovarian cancer stem cells by neutralizing the Wnt β-catenin pathway, disrupting the interaction between β-catenin and CD24 and suppressing autophagy.
    Sundaram SM; Varier L; Fathima KZ; Dharmarajan A; Warrier S
    Life Sci; 2023 Mar; 316():121384. PubMed ID: 36646377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secreted frizzled-related protein 4 inhibits glioma stem-like cells by reversing epithelial to mesenchymal transition, inducing apoptosis and decreasing cancer stem cell properties.
    Bhuvanalakshmi G; Arfuso F; Millward M; Dharmarajan A; Warrier S
    PLoS One; 2015; 10(6):e0127517. PubMed ID: 26030909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secreted Frizzled-related protein 4 (sFRP4) chemo-sensitizes cancer stem cells derived from human breast, prostate, and ovary tumor cell lines.
    Deshmukh A; Kumar S; Arfuso F; Newsholme P; Dharmarajan A
    Sci Rep; 2017 May; 7(1):2256. PubMed ID: 28536422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Encapsulated human mesenchymal stem cells (eMSCs) as a novel anti-cancer agent targeting breast cancer stem cells: Development of 3D primed therapeutic MSCs.
    Mandal S; Arfuso F; Sethi G; Dharmarajan A; Warrier S
    Int J Biochem Cell Biol; 2019 May; 110():59-69. PubMed ID: 30735730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway.
    Liu T; Hu K; Zhao Z; Chen G; Ou X; Zhang H; Zhang X; Wei X; Wang D; Cui M; Liu C
    Oncotarget; 2015 Dec; 6(39):41638-49. PubMed ID: 26497855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic demethylation of sFRPs, with emphasis on sFRP4 activation, leading to Wnt signalling suppression and histone modifications in breast, prostate, and ovary cancer stem cells.
    Deshmukh A; Arfuso F; Newsholme P; Dharmarajan A
    Int J Biochem Cell Biol; 2019 Apr; 109():23-32. PubMed ID: 30710752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells.
    Warrier S; Balu SK; Kumar AP; Millward M; Dharmarajan A
    Oncol Res; 2013; 21(2):93-102. PubMed ID: 24406045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft.
    Martins-Neves SR; Paiva-Oliveira DI; Fontes-Ribeiro C; Bovée JVMG; Cleton-Jansen AM; Gomes CMF
    Cancer Lett; 2018 Feb; 414():1-15. PubMed ID: 29126913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype.
    Jang GB; Kim JY; Cho SD; Park KS; Jung JY; Lee HY; Hong IS; Nam JS
    Sci Rep; 2015 Jul; 5():12465. PubMed ID: 26202299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Cancer Stem Cell Metabolism by Secreted Frizzled-Related Protein 4 (sFRP4).
    Deshmukh A; Arfuso F; Newsholme P; Dharmarajan A
    Cancers (Basel); 2018 Jan; 10(2):. PubMed ID: 29385093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secreted frizzled-related protein 4 is silenced by hypermethylation and induces apoptosis in beta-catenin-deficient human mesothelioma cells.
    He B; Lee AY; Dadfarmay S; You L; Xu Z; Reguart N; Mazieres J; Mikami I; McCormick F; Jablons DM
    Cancer Res; 2005 Feb; 65(3):743-8. PubMed ID: 15705870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginsenoside-Rb1 targets chemotherapy-resistant ovarian cancer stem cells via simultaneous inhibition of Wnt/β-catenin signaling and epithelial-to-mesenchymal transition.
    Deng S; Wong CKC; Lai HC; Wong AST
    Oncotarget; 2017 Apr; 8(16):25897-25914. PubMed ID: 27825116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LGR5 Promotes Breast Cancer Progression and Maintains Stem-Like Cells Through Activation of Wnt/β-Catenin Signaling.
    Yang L; Tang H; Kong Y; Xie X; Chen J; Song C; Liu X; Ye F; Li N; Wang N; Xie X
    Stem Cells; 2015 Oct; 33(10):2913-24. PubMed ID: 26086949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sonic hedgehog and Wnt/β-catenin pathways mediate curcumin inhibition of breast cancer stem cells.
    Li X; Wang X; Xie C; Zhu J; Meng Y; Chen Y; Li Y; Jiang Y; Yang X; Wang S; Chen J; Zhang Q; Geng S; Wu J; Zhong C; Zhao Y
    Anticancer Drugs; 2018 Mar; 29(3):208-215. PubMed ID: 29356693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt/β-catenin signaling mediates the suppressive effects of diallyl trisulfide on colorectal cancer stem cells.
    Zhang Q; Li XT; Chen Y; Chen JQ; Zhu JY; Meng Y; Wang XQ; Li Y; Geng SS; Xie CF; Wu JS; Zhong CY; Han HY
    Cancer Chemother Pharmacol; 2018 Jun; 81(6):969-977. PubMed ID: 29594332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cadherin 11 Inhibition Downregulates β-catenin, Deactivates the Canonical WNT Signalling Pathway and Suppresses the Cancer Stem Cell-Like Phenotype of Triple Negative Breast Cancer.
    Satriyo PB; Bamodu OA; Chen JH; Aryandono T; Haryana SM; Yeh CT; Chao TY
    J Clin Med; 2019 Jan; 8(2):. PubMed ID: 30691241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.